Taking the depressed “person” into account before moving into personalized or precision medicine

World Psychiatry

Volumn 15, Issue 3, 2016, Pages 236-237

  Demyttenaere, Koen ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; HYPERICUM EXTRACT; PLACEBO; SERTRALINE;

ANXIETY; CLINICAL FEATURE; DEMOGRAPHY; DEPRESSION; DEPRESSION ASSESSMENT; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; FATIGUE; HAMILTON DEPRESSION RATING SCALE; HUMAN; INDEPENDENT LIVING; INSOMNIA; INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY; MAJOR DEPRESSION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NOTE; PATIENT ATTITUDE; PERSONALIZED MEDICINE; PLACEBO EFFECT; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNEMPLOYMENT;

EID: 84988442830     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20362     Document Type: Note

References (9)

1. Perlis RH. World Psychiatry 2016;15:228-35.
2. Zimmerman M, Posternak M, Friedman M et al. Am J Psychiatry 2014;161:1285-9.
3. McGoey L. Hist Hum Sci 2010;23:58-78.
4. Sinyor M, Levitt AJ, Cheung AH et al. J Clin Psychiatry 2010;71:270-9.
5. Chen JA, Papakostas GI, Youn SJ et al. J Clin Psychiatry 2011;72:1669-76.
6. Demyttenaere K, Reines EH, Lönn SL et al. Prim Care Companion CNS Disord 2011;13(4).
7. Demyttenaere K, Verhaeghen A, Dantchev N et al. Prim Care Companion J Clin Psychiatry 2009;11:307-31.
8. Fried EI, Epskamp S, Nesse RM et al. J Affect Disord 2016;189:314-20.
9. Demyttenaere K, Donneau AF, Albert A et al. J Affect Disord 2015;174:390-6.